Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) EPS (Basic) (2018 - 2026)

TELA Bio has reported EPS (Basic) over the past 8 years, most recently at -$0.17 for Q4 2025.

  • For Q4 2025, EPS (Basic) changed 0.0% year-over-year to -$0.17; the TTM value through Dec 2025 reached -$0.83, up 37.59%, while the annual FY2025 figure was -$0.83, 37.59% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.17 at TELA Bio, up from -$0.19 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.17 in Q4 2025 and troughed at -$0.88 in Q2 2022.
  • A 5-year average of -$0.46 and a median of -$0.5 in 2022 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): plummeted 54.39% in 2022 and later skyrocketed 67.92% in 2024.
  • Year by year, EPS (Basic) stood at -$0.59 in 2021, then grew by 18.64% to -$0.48 in 2022, then dropped by 10.42% to -$0.53 in 2023, then skyrocketed by 67.92% to -$0.17 in 2024, then increased by 0.0% to -$0.17 in 2025.
  • Business Quant data shows EPS (Basic) for TELA at -$0.17 in Q4 2025, -$0.19 in Q3 2025, and -$0.22 in Q2 2025.